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1. Introduction 
The human placenta synthesizes a lactogenic hor- 
mone, (HPL), as one of its major proteins. During 
pregnancy, HPL appears at maximal leveis at about 
30 weeks [l-3]. It has also been shown that in term 
placen.tal tissue slices, HPL constitutes one of the 
primary proteins synthesized [4-61. Although term 
serum HPL levels are much higher than at first 
trimester, it is not clear as to the rate of HPL synthe- 
sized during pregnancy [7]. 
We have previously shown that labeled HPL could 
be synthesized in a reconstituted cell-free system con- 
taining purified placental ribosomes and a cell sap 
fraction derived from ascites tumor cells [8]. How- 
ever, it was difficult to quantitate the cell-free 
synthesis of the labeled hormone as a function of 
pregnancy due to high backgrounds of radioactivity. 
Here, we report on the levels of HPL synthesized by 
ribosomes isolated from human placentae at different 
periods of gestation using a convenient and reliable 
commercial radioimmunoassay system. The data are 
consistent with the hypothesis tha’t the amount of 
this human hormone synthesized reflects the in vivo 
differentiation of the placenta during hregnancy. 
2. Materials and methods 
[35 S] Methionine was obtained from Amersham 
Searle. Human placental lactogen (95% pure) was 
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purchased from Nutritional Biochemicals. The radio- 
rmmunoassay kit tbr HPL, the components of which 
will be described below, was obtained from New 
England Nuclear. Rat liver tRNA was generously 
provided by Dr. Dolph, Hatfield. 
Polysomes derived from either first trimester or 
third trimester placenta and ascites tumor cell sap 
were prepared as previously described [8]. The cell- 
free system was composed of 30 mM Tris-HCl 
(PH 7.5), 3.3 mM magnesium acetate, 70 mM KCl, 
7 mM 2-mercaptoethanol, 1 mM ATP, 0.1 mM GTP, 
0.6 mM CTP, 10 mM creatine phosphate, 0.16 mg/ml 
creatine kinase, 40 PM each of 20 unlabeled amino 
acids, and 60 pg/ml of rat liver tRNA. The volume of 
the reaction mixtures was 0.6 ml. The reaction mixtures 
were incubated for 120 min at 33°C. Following incu- 
bation, the reactions were terminated with 0.2 mg/ml of 
pancreatic rihonuclease. This was incubated for an 
additional 15 min at 33°C. l’he samples were then 
dialyzed overnight in the cold against 500 vol of 0.1 M 
NH4HC03. Following dialysis, the samples were 
lyophilized and the residue resuspended in a buffer 
containing 0.1 M Tris acetate (pH 7.5) and 0.25% 
bovine serum albumin. This buffer, HPL antiserum 
and [’ 25 I]HPL (specific activity 1 O-20 pCi/pg) are 
all components of an immunoassay unit (Cat. #NEA- 
23) supplied by New England Nuclear Co. The 
resulting suspension was centrifuged at 3000 g for 
10 min. Aliquots of the supernatant solution were 
then assayed according to the protocol that accompa- 
nies the radioimmunoassay unit except that the total 
volume of the incubation mixture was reduced by 
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l/2. This immunoassay utilizes some of the methodo- 
logy employed by Saxena et al. [2]. 
3. Results and discussion 
In assays employing precipitating antibody systems, 
the synthesis of radioactive protein is measured. Here, 
the immunoassay is based on an isotope dilution 
which measures the synthesis of unlabeled protein by 
its competition with a labeled ligand for antibody sites 
191. 
Immunoreactive material was synthesized on poly- 
somes prepared from term placenta (table 1). 
Pancreatic ribonuclease, or puromycin addition, or 
omission of cell sap eliminated the net synthesis. 
(A background of immunoreactive material in the 
system may come from partially completed chains 
or adsorption of HPL to the polysomes during homo- 
genization). The recovery of immunoreactive protein 
was determined by processing a known quantity of 
authentic HPL in the complete system treated with 
ribonuclease. The recovery of immunoassayable HPL 
was greater than 70%. 
The synthesis of this immunoreactive material was 
specific for the placental cell-free system. No detect- 
able product was observed in a cell-free system con- 
Table 1 
Immunoassay using HPL antibody for protein synthesized 
in a cell-free system containing term placental ribosomes 
Conditions of cell-free system 
lmmunoreactive protein 
(rig/A 260 of ribosomes) 
Complete 2.4 
Complete, unincubated 0.50 
Complete + RNase at zero time 0.60 
Complete + 1 mM puromycin 0.55 
Minus cell sap 0.40 
The reaction mixtures, in addition to the components de- 
scribed in the Materials and methods section, contained 9 
A 2e0 knits of ribosomes and the equivalent of 360 Gg of cell- 
sap protein per 0.60 ml. The reaction mixtures were treated 
as described in the text. Aliquots of the supernate were added 
to the immunoassay incubation medium. The amount of im- 
munoreactive material was expressed as ng of HPL/A,,, of 
ribosomes initially added to the cell-free system (1 A,,, = 
20 pmoles). 
taining polysomes prepared from either rat liver or a 
solid hamster tumor. The synthesis of immunoreactive 
material, specific for placental polysomes strongly 
suggests that the material detected in the placental 
system is HPL whose synthesis is directed by the cor- 
responding mRNA. In further support of this, all the 
specifically immunoreactive protein co-migrated with 
authentic HPL in acrylamide gel electrophoresis (data 
not shown). 
In terms of the amount of ribosomes added to the 
immunoassay system, the level of detectable HPL was 
linear up to the equivalent of 1.5 AZ60 of ribosomes 
(fig. 1). It can also be seen that it is possible to detect 
at least 0.3 ng of HPL. 
A,,, of Ribosomes 
Fig. 1. The effects of increasing quantities of the in vitro 
synthesized reaction mixture on the radioimmunoassay 
system. Two reaction mixtures, one containing ribonuclease 
at zero time, the other treated with ribonuclease after 2 hr 
of incubation, were processed for immunoassay as described 
in the text. The data are expressed as ng of HPL detected 
as a function of the amount of ribosome equivalents added 
to the immunoassay incubation medium. 
The levels of HPL synthesized in the cell-free 
system containing term polysomes was about 4 times 
greater than in a system containing first trimester 
polysomes (table 2). The lower amounts of HPL 
synthesized in the first trimester system were not the 
apparent result of lower efficiency of protein synthesis 
since with equal quantities of ribosomes, the amount 
of [35 Slmethionine incorporated in both cell-free 
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The levels of HPL synthesized in cell-free system containing first trimester or term ribosomes 
Expt. Source of ribosomes 
[35S]Met. 
incorp./0.06 ml 
Immunoreactive protein 
(ng/Azso of ribosomes) 
- RNase + RNase 
A 
B 
Term 830 000 
First frimester 640 000 
Term 660 000 
First trimester 690 000 
2.80 0.53 
0.42 Not detect. 
3.00 0.50 
0.62 Not detect. 
The 0.6 ml reaction mixture contained 360 rg of protein ascites tumor cell sap, 6 A,,, 
units (Expt. A) and 2.6 Aaeo units (Expt. B) of term ribosomes and first trimester ribosomes. 
Before the addition of unlabeled amino acids, aliquots of the assay system were incubated 
with 0.5 nM [35S]methionine (specific activity - 195 Ci/mmole), and a mixture of 19 minus 
methionine cold amino acids. To the remaining mixture, all 20 unlabeled amino acids were 
added. Both labeled and unlabeled reactions were incubated for 2 hr at 33°C. The amount 
of [ 35S]methionlne incorporated was quantitated by precipitating the proteins with trichloro- 
acetic acid, filtering, and then counting the filters in a liquid scintillation counter. The fist 
trimester placentae were obtained at 8-12 weeks of gestation. 
systems was comparable. The data thus parallel the 
serum levels of hormone seen during pregnancy [l-3] 
and the levels of HPL secreted from first trimester 
and term placental slices incubated in vitro [ 161. 
The trpphoblast cellular population of the placenta 
is composed of 2 types: relatively undifferentiated 
cytotrophoblasts and a more differentiated syncytium. 
The cytotrophoblasts are apparently the generative 
cells for the syncytium [lo- 131, and the latter is the 
site of synthesis for HPL [ 141. It has been shown 
morphologically that during gestation there is a 
decrease in the number of cytotrophoblasts and an 
increase in the proportion of syncytium of the placent- 
al villi [ 151. Thus, the increased HPL synthesis seen 
in the cell-free system containing term ribosomes may 
be indicative of the continual differentiation of the 
placenta. More specifically, the higher hormone levels 
may result from a recruitment of the more primitive 
cytotrophoblasts to the differentiated syncytium. 
Thus, it is probable that as a result of an increased 
fraction of syncytium at term, there is a correspond- 
ingly greater proportion of HPLmRNA. 
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